Contact Us   Having technical issues or questions regarding this product?
Please Contact Us.
BEI Resources currently limits the total number of "Made to Order" items which can be ordered by a registrant to 10 "Made to Order" items per 6 month period. Please check the Availability Status on the items you are ordering and limit orders appropriately.
NR-45872  Staphylococcus aureus, HIP07930
Price: All BEI Resources products are provided
at no cost to registered researchers.
Organism: Staphylococcus aureus
Designations: HIP07930
Biosafety Level: 2
Availability Status: In Stock
Store at: -60°C or colder
Contributor: NARSA
Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

Staphylococcus aureus (S. aureus), strain HIP07930 (also referred to as USA600, 99758 and NRS22) was isolated in 1999 from the bloodstream of an adult female ICU patient in New York, USA.

S. aureus, strain HIP07930 is a hosptial-acquired methicillin-resistant S. aureus (HA-MRSA) strain. Strain HIP07930 was deposited as resistant to erythromycin, clindamycin, trimethoprim/sulfamethoxazole, gentamicin and levofloxacin; positive for mec (subtype II); negative for PVL, tsst, sea, seb, sec, sed and see; MLST sequence type (ST) 45; pulsed-field type USA600; eGenomic spa type 10, eGenomic spa repeats A2AKEEMBKM; Ridom spa type t266; agr group I.S. aureus, strain HIP 07930 is a USA600 isolate. USA600 isolates have the same MLST profile (ST 45), SCCmec (subtype II or IV), agr group (I) and spa repeats (A2AKEEMBKB). They are PVL negative and resistant to erthromycin and clindamycin. Isolates are predominantly found in nares of healthy individuals and bloodstream infections. These isolates are associated with a higher rate of clinical failure and mortality, particularly those with a heterogeneous vancomycin-intermediate S. aureus (hVISA) phenotype. While USA600 isolates are uncommon the United States, the clonally-related Berlin strain is widespread throughout Germany, the Netherlands, and Ontario, Cananda.

Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Citations: Acknowledgment for publications should read "The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain HIP07930, NR-45872."
Additional Information: NARSA NRS22
For a list of permits that may be required for shipping this product and to set the permit information preferences; please select a country from the drop down below.

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.

Return to Top

Notices and Disclaimers

BEI Resources products are intended for laboratory research purposes only. They are not intended for use in humans.

While BEI Resources uses reasonable efforts to include accurate and up-to-date information on this site, BEI Resources makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. BEI Resources does not warrant that such information has been confirmed to be accurate.

Back to My Search